InvestorsObserver is giving Teva Pharmaceutical Industries Ltd (TEVA) an Analyst Rating Rank of 13, meaning TEVA is ranked higher by analysts than 13% of stocks. The average price target for TEVA is $10.125 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating TEVA a Buy today. Find out what this means to you and get the rest of the rankings on TEVA!
You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.
InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.
What's Happening With Teva Pharmaceutical Industries Ltd Stock Today?
Teva Pharmaceutical Industries Ltd (TEVA) stock has fallen -0.06% while the S&P 500 has risen 0.22% as of 10:00 AM on Wednesday, Jun 29. TEVA has fallen -$0.01 from the previous closing price of $7.84 on volume of 1,134,407 shares. Over the past year the S&P 500 is lower by -10.76% while TEVA has fallen -21.83%. TEVA lost -$0.56 per share the over the last 12 months.
Click Here to get the full Stock Report for Teva Pharmaceutical Industries Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
